Display options
Share it on

Exp Ther Med. 2015 Aug;10(2):579-583. doi: 10.3892/etm.2015.2536. Epub 2015 May 29.

Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 .

Experimental and therapeutic medicine

Ming-Xin Ren, Xiao-Hui Deng, Fang Ai, Guo-Yan Yuan, Hai-Yan Song

Affiliations

  1. Department of Human Anatomy, Xinxiang Medical University, Xinxiang, Henan 453003, P.R. China.
  2. Department of Neurosurgery, First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453000, P.R. China.

PMID: 26622357 PMCID: PMC4508991 DOI: 10.3892/etm.2015.2536

Abstract

Quercetin is a hydrophobic agent that demonstrates potential anticancer activity. The aim of the present study was to observe the effects of quercetin on the proliferation and apoptosis of the ovarian cancer cell line SKOV-3, and to provide a foundation for the treatment of ovarian cancer using this agent. Ovarian cancer SKOV-3 cells were treated with quercetin at different doses. The inhibitory effect of quercetin on proliferation was detected using the MTT assay and the inhibition rate was calculated. Cell apoptosis was determined using Hoechst staining, and western blot analysis was used to analyze changes in the expression levels of survivin protein. The effects of quercetin on the cell cycle and apoptosis of the SKOV-3 cell line were analyzed using flow cytometry. Quercetin inhibited the proliferation of SKOV-3 cells in a time- and dose-dependent manner. Furthermore, Hoechst staining showed that quercetin induced SKOV-3 cell apoptosis. The protein expression levels of survivin were reduced as the concentration of quercetin increased. Flow cytometric analysis showed that quercetin caused ovarian cancer SKOV-3 cell cycle arrest in the G

Keywords: apoptosis; ovarian cancer; proliferation; quercetin; survivin

References

  1. Anticancer Res. 2013 May;33(5):1941-50 - PubMed
  2. Cancer Res. 1992 Dec 1;52(23):6676-81 - PubMed
  3. Eur J Immunol. 2005 Feb;35(2):584-92 - PubMed
  4. Lancet Oncol. 2012 Mar;13(3):285-91 - PubMed
  5. Pak J Biol Sci. 2013 Oct 15;16(20):1212-5 - PubMed
  6. Oncogene. 2003 Aug 21;22(35):5504-14 - PubMed
  7. J Infus Nurs. 2009 Nov-Dec;32(6):314-22 - PubMed
  8. Anticancer Agents Med Chem. 2013 Sep;13(7):1025-31 - PubMed
  9. Cancer Sci. 2014 May;105(5):520-7 - PubMed
  10. CA Cancer J Clin. 2011 May-Jun;61(3):183-203 - PubMed
  11. Asian Pac J Cancer Prev. 2012;13(11):5843-8 - PubMed
  12. Carcinogenesis. 2004 May;25(5):647-59 - PubMed
  13. Food Chem Toxicol. 2012 Sep;50(9):3375-83 - PubMed
  14. Cancer Res. 2010 Apr 15;70(8):3382-90 - PubMed
  15. Front Biosci. 2006 Sep 01;11:2275-85 - PubMed
  16. Mol Cancer Ther. 2007 Sep;6(9):2591-9 - PubMed

Publication Types